Last verified: today
Cannabis Sativa Extract (CBD)
Also known as: Cannabidiol, CBD, Hemp Extract, Full-Spectrum CBD, Broad-Spectrum CBD, CBD Isolate
Evidence under review. — Not yet rated
Plant-derived compound with preliminary evidence for anxiety and sleep; most supplement claims lack strong proof.
-
What it does
CBD (cannabidiol) is a non-intoxicating compound extracted from the Cannabis sativa plant. It interacts with the body's endocannabinoid system, which plays a role in regulating mood, sleep, pain...
-
Evidence quality
Evidence base hasn't been formally rated yet. See research below.
-
Clinical dose
No established dose from provided studies
What the Science Says
CBD (cannabidiol) is a non-intoxicating compound extracted from the Cannabis sativa plant. It interacts with the body's endocannabinoid system, which plays a role in regulating mood, sleep, pain perception, and immune response. Preliminary research and one FDA-approved pharmaceutical form (Epidiolex) suggest it may help with certain seizure disorders, anxiety, and sleep disturbances, though most supplement-grade CBD products lack rigorous clinical backing for their specific claims.
What It Doesn't Do
Won't get you high — CBD is not THC. No solid proof it cures anxiety, chronic pain, or inflammation on its own. Not a proven cancer treatment despite widespread online claims. No strong evidence it builds muscle or boosts athletic performance. 'Full-spectrum' labels don't automatically mean more effective. Not a substitute for prescribed medications.
Evidence-Based Benefits
May reduce situational anxiety symptoms in some adults based on preliminary research.
Weak EvidenceEffective at: No established dose from provided studies
May improve sleep onset and duration in people with anxiety-related sleep issues.
Weak EvidenceEffective at: No established dose from provided studies
FDA-approved pharmaceutical CBD (Epidiolex) reduces seizure frequency in rare epilepsy syndromes.
Weak EvidenceEffective at: No established dose from provided studies
Absorption & Bioavailability
Poor to Moderate — oral bioavailability is low (roughly 6–19% in general literature) due to first-pass liver metabolism. Sublingual and inhaled routes absorb faster and more efficiently. Fat-soluble; taking with food may improve absorption. No bioavailability data from provided studies.
Red Flags to Watch For
- No provided clinical studies — all claims here are based on general knowledge, not reviewed research papers
- CBD can interact with common medications (e.g., blood thinners, antiepileptics) by inhibiting liver enzymes (CYP450)
- Supplement-grade CBD products are not FDA-regulated for purity or potency — third-party testing is essential
- Products may contain undisclosed THC levels, which can cause a failed drug test
- Dosing is highly inconsistent across products; label claims frequently mismatch actual content
- Marketing claims (pain relief, anti-anxiety, anti-cancer) often far outpace the available evidence
Research Sources
- General knowledge — no research papers were provided for this analysis. All assessments are conservative and based on publicly known information only.
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-05-25